Pforzheim Tricuspid Valve Registry - Outcomes of Percutaneous Tricuspid Valve Repair
Recruiting · NCT05179616 · Observational (researchers observe without assigning treatment) · Lead sponsor: Helios Klinikum Pforzheim
View the official record on ClinicalTrials.gov →Interventions studied
Transcatheter edge-to-edge tricuspid valve repair
What this trial is about
The Pforzheim Tricuspid Valve Registry study is designed to confirm the safety and performance of the TriClip™ device in a contemporary real-world setting in critically ill patients. The observational trial is a prospective, single arm, open-label, single-center, post market registry.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Subjects (\>=18 years age) have severe tricuspid regurgitation and are symptomatic despite medical therapy.
- Subjects eligible to receive the TriClip™
- Subjects must provide written informed consent prior to study procedure.
Exclusion criteria
- Subjects participating in another clinical study that may impact the follow-up or results of this study.
Where it is running
1 location listed.
- Helios Klinikum Pforzheim - Pforzheim, Germany